Skip to main content
. 2017 Sep 4;7:10380. doi: 10.1038/s41598-017-10789-x

Table 2.

Multivariate Analysis of Breast Cancer-specific Survival (BCSS) and Overall Survival (OS) Predictors Using a Cox Proportional Hazards Model.

Variables BCSS OS
HR (95% CI) P HR (95% CI) P
Histological type
IDC-L versus IDC 1.00 (0.96 to 1.05) 0.837 0.93 (0.90 to 0.97) <0.001
IDC-L versus ILC 0.99 (0.93 to 1.06) 0.814 1.00 (0.95 to 1.05) 0.970
Year of diagnosis
1998–2002 1.24 (1.20 to 1.27) <0.001 1.22 (1.20 to 1.25) <0.001
2003–2007 Reference
Age at diagnosis
≤50 y 0.89 (0.87 to 0.91) <0.001 0.56 (0.55 to 0.58) <0.001
>50 y Reference
Race
Black 1.30 (1.26 to 1.35) <0.001 1.28 (1.24 to 1.32) <0.001
Othersa 0.87 (0.83 to 0.92) <0.001 0.81 (0.78 to 0.84) <0.001
White Reference
Marital status
Married 0.82 (0.80 to 0.84) <0.001 0.69 (0.67 to 0.70) <0.001
Unmarriedb Reference
Grade
1 0.50 (0.47 to 0.53) <0.001 0. 28 (0.80 to 0.85) <0.001
2 Reference
3 and UDc 1.47 (1.43 to 1.52) <0.001 1.23 (1.20 to 1.26) <0.001
Tumor size (cm)
<2 0.49 (0.48 to 0.51) <0.001 0.64 (0.62 to 0.65) <0.001
2–5 Reference
>5 1.55 (1.49 to 1.60) <0.001 1.49 (1.45 to 1.54) <0.001
Positive nodes
0 0.29 (0.28 to 0.30) <0.001 0.42 (0.41 to 0.44) <0.001
1–3 0.57 (0.54 to 0.59) <0.001 0.60 (0.59 to 0.62) <0.001
4–9 Reference
≥10 1.34 (1.29 to 1.40) <0.001 1.40 (1.35 to 1.45) <0.001
ER status
Negative 1.36 (1.31 to 1.41) <0.001 1.19 (1.15 to 1.22) <0.001
Positive Reference
PR status
Negative 1.37 (1.32 to 1.42) <0.001 1.23 (1.20 to 1.27) <0.001
Positive Reference
Radiation
No 1.16 (1.13 to 1.20) <0.001 1.29 (1.26 to 1.32) <0.001
Yes Reference
Surgery type
No 1.42 (1.32 to 1.54) <0.001 1.34 (1.25 to 1.44) <0.001
Lumpectomy 0.85 (0.82 to 0.87) <0.001 0.87 (0.85 to 0.89) <0.001
Mastectomy Reference

Note:

aIncluding American Indian/Alaskan native, Asian/Pacific Islander, and others-unspecified.

bIncluding divorced, separated, single (never married), and widowed.

cIncluding grade 3 and undifferentiated.

Abbreviations: BCSS: breast cancer-specific survival; OS: overall survival; HR: hazard ratio; CI: confidence interval; IDC-L: invasive ductal carcinoma with lobular features; IDC: invasive ductal carcinoma; ILC: invasive lobular carcinoma; ER: estrogen receptor; PR: progesterone receptor.